These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22128639)

  • 1. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deployment-related testing and treatment for latent tuberculosis infection, Part I.
    Mancuso JD; Keep LW
    Mil Med; 2011 Aug; 176(8):865-9. PubMed ID: 21882774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: number of tuberculosis tests and diagnoses of latent tuberculosis infection in active component service members, U.S. Armed Forces, January 2004-December 2014.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2014 Dec; 21(12):8-10; discussion 9-10. PubMed ID: 25555209
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculosis as a force health protection threat to the United States military.
    Sanchez JL; Sanchez JL; Cooper MJ; Hiser MJ; Mancuso JD
    Mil Med; 2015 Mar; 180(3):276-84. PubMed ID: 25735017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are the recommendations on tuberculosis screening still valid? Interferon gamma release assay (IGRA) and/or tuberculin skin test for diagnosis of latent tuberculosis infection (LTBI)].
    Ernst D; Witte T; Schmidt RE; Meyer-Olson D
    Z Rheumatol; 2013 Nov; 72(9):846-50. PubMed ID: 23942562
    [No Abstract]   [Full Text] [Related]  

  • 8. The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.
    Tomsic M; Rotar Z
    Ann Rheum Dis; 2012 Nov; 71(11):1909-11. PubMed ID: 22805974
    [No Abstract]   [Full Text] [Related]  

  • 9. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study.
    Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032
    [No Abstract]   [Full Text] [Related]  

  • 11. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approach to latent tuberculosis diagnosis and treatment among medical center occupational health physicians.
    Vinnard C; Linkin D; Behrman A
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1262-5. PubMed ID: 23143368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active tuberculosis and recent overseas deployment in the U.S. Military.
    Nevin RL
    Am J Prev Med; 2010 Dec; 39(6):e39-40; author reply e40. PubMed ID: 21084066
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and implementation of a cohort review for latent TB infection.
    Mancuso JD; Aaron CL
    Chest; 2015 Jan; 147(1):e25-e26. PubMed ID: 25560872
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for Latent Tuberculosis Infection in Adults.
    Fan T; Rogers A
    Am Fam Physician; 2017 Nov; 96(10):675-676. PubMed ID: 29431394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

  • 17. Immigration screening for latent tuberculosis infection.
    Denholm JT
    Med J Aust; 2013 Jun; 198(10):524. PubMed ID: 23725254
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy.
    Woodfield G; Passey-Heaton B; Chakrabarti A; Pozniak A; Loebinger MR
    Eur Respir J; 2014 Nov; 44(5):1369-72. PubMed ID: 25186258
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis screening in a dialysis unit: detecting latent tuberculosis infection is only half the problem.
    Brij SO; Beck SC; Kleemann F; Jack AL; Wilkinson C; Enoch DA
    J Hosp Infect; 2014 Aug; 87(4):241-4. PubMed ID: 25027226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
    Wilson FA; Miller TL; Stimpson JP
    Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.